Evidence map›Paper›PMID 37606819›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2024

Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.

Hanzhao Zhang, Dardan Konjusha, Nima Rafati, Tatsiana Tararuk, Finn Hallböök

Open access · hybridAbstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hanzhao ZhangDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Dardan KonjushaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Nima RafatiNational Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Tatsiana TararukDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Finn HallböökDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Finn.Hallbook@igp.uu.se.
Uppsala University · SEScience for Life Laboratory · SE

Funding

ARMEC Lindebergs foundation 2023-3Barncancerfonden PR2019-0068Hjärnfonden FO2020-0291Stiftelsen Kronprinsessan Margaretas Arbetsnämnd för Synskadade 2022-029, 2021-040
6 · The paper itself

Abstract

purposeRetinoblastoma, a childhood cancer, is most frequently caused by bi-allelic inactivation of RB1 gene. However, other oncogenic mutations such as MYCN amplification can induce retinoblastoma with proficient RB1. Previously, we established RB1-proficient MYCN-overexpressing retinoblastoma models both in human organoids and chicken. Here, we investigate the regulatory events in MYCN-induced retinoblastoma carcinogenesis based on the model in chicken.

methodsMYCN transformed retinal cells in culture were obtained from in vivo MYCN electroporated chicken embryo retina. The expression profiles were analysed by RNA sequencing. Chemical treatments, qRT-PCR, flow cytometry, immunohisto- and immunocytochemistry and western blot were applied to study the properties and function of these cells.

resultsThe expression profile of MYCN-transformed retinal cells in culture showed cone photoreceptor progenitor signature and robustly increased levels of E2Fs. This expression profile was consistently observed in long-term culture. Chemical treatments confirmed RB1 proficiency in these cells. The cells were insensitive to p53 activation but inhibition of E2f efficiently induced cell cycle arrest followed by apoptosis.

conclusionIn conclusion, with proficient RB1, MYCN-induced high level of E2F expression dysregulates the cell cycle and contributes to retinoblastoma carcinogenesis. The increased level of E2f renders the cells to adopt a similar mechanistic phenotype to a RB1-deficient tumour.

Indexed as

Retinal NeoplasmsRetinoblastomaAnimalsCarcinogenesisChick EmbryoChickensChildHumansN-Myc Proto-Oncogene ProteinRetinoblastoma Binding ProteinsUbiquitin-Protein LigasesMYCN protein, humanN-Myc Proto-Oncogene ProteinRB1 protein, humanRetinoblastoma Binding ProteinsUbiquitin-Protein LigasesAnimal modelChickenE2FIntraocular cancerMYCNRB1 proficientRetinoblastoma

Identifiers

PMID37606819
PMCPMC10899388
OpenAlexW4386046969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.